Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Washer 

Boston Scientific diskutieren

Boston Scientific

WKN: 884113 / Symbol: BSX / Name: Boston Scient / Aktie / Ausrüstung & Versorgung / Large Cap /

42,07 €
2,02 %

Einschätzung Buy
Rendite (%) -21,41 %
Kursziel 77,00
Veränderung
Endet am 13.04.27

Boston Scientific (BSX) was given a new $90.00 price target by Mizuho. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -23,65 %
Kursziel 76,39
Veränderung
Endet am 15.04.27

Boston Scientific (BSX) had its price target lowered by Truist Financial Corporation from $92.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -19,84 %
Kursziel 72,17
Veränderung
Endet am 21.04.27

Boston Scientific (BSX) had its price target lowered by Stifel Nicolaus from $90.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -21,54 %
Kursziel 85,15
Veränderung
Endet am 22.04.27

Boston Scientific (BSX) had its price target lowered by Barclays PLC from $124.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -24,27 %
Kursziel 85,15
Veränderung
Endet am 22.04.27

Boston Scientific (BSX) had its price target lowered by Jefferies Financial Group Inc. from $110.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -24,50 %
Kursziel 65,82
Veränderung
Endet am 23.04.27

Boston Scientific (BSX) had its price target lowered by Needham & Company LLC from $97.00 to $77.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -24,50 %
Kursziel 66,67
Veränderung
Endet am 23.04.27

Boston Scientific (BSX) had its price target lowered by Robert W. Baird from $86.00 to $78.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -24,50 %
Kursziel 72,66
Veränderung
Endet am 23.04.27

Boston Scientific (BSX) had its price target lowered by Truist Financial Corporation from $90.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -26,26 %
Kursziel 82,06
Veränderung
Endet am 23.04.27

Boston Scientific (BSX) was given a new $96.00 price target by Barclays PLC. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -25,09 %
Kursziel 85,48
Veränderung
Endet am 23.04.27

Boston Scientific (BSX) was given a new $100.00 price target by Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,40 %
Kursziel 68,85
Veränderung
Endet am 18.05.27

Boston Scientific (BSX) had its "buy" rating reaffirmed by BTIG Research. They now have a $80.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,75 %
Kursziel 66,27
Veränderung
Endet am 18.05.27

Boston Scientific (BSX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $77.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,75 %
Kursziel 58,52
Veränderung
Endet am 18.05.27

Boston Scientific (BSX) had its price target lowered by Bank of America Corporation from $105.00 to $68.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,26 %
Kursziel 64,43
Veränderung
Endet am 19.05.27

Boston Scientific (BSX) had its price target lowered by Robert W. Baird from $78.00 to $75.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Boston Scientific (BSX) had its "buy" rating reaffirmed by Citigroup Inc..
Ratings data for BSX provided by MarketBeat

Boston Scientific (BSX) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,02 %
Kursziel 55,12
Veränderung
Endet am 04.06.27

Boston Scientific (BSX) had its price target lowered by Truist Financial Corporation from $85.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat